Ustekinumab Versus Adalimumab in Patients With Crohn's Disease. Segal JP. Gastroenterology 2022;163:1115-1116.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Segal JP. Ustekinumab Versus Adalimumab in Patients With Crohn's Disease. Gastroenterology 2022;163:1115-1116.
PMID: 35850196